関連する実験動画

Updated: Jun 24, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

ビタミンAサプリメントと子供の生存率

M G Herrera1, P Nestel, A el Amin

  • 1Harvard Institute for International Development, Cambridge, Massachusetts 02138.

Lancet (London, England)
|August 1, 1992
PubMed
まとめ

スーダンでは,半年に一度の高用量ビタミンAサプリメント摂取は,幼児死亡率を低下させなかった. 貧困,不十分な衛生状態,不適切な食事などの要因は,子供の生存率を改善するために依然として重要です.

キーワード:
アフリカ アフリカ アフリカ アフリカアラブ諸国 アラブ諸国生物学 生物学 生物学とは幼児死亡率 幼児死亡率子どもの栄養 子供の栄養子どもの生存率 (Child Survival) は,子供の生存率 (Child Survival) を表しています.人口統計的要因 人口統計的要因発展途上国 開発途上国病気 病気 病気ダブルブラインド研究.経済的な要因 経済的な要因健康 健康 健康 健康とは寿命の長さについて栄養失調 栄養失調 栄養失調 栄養失調 栄養失調発病率 発病率について死亡率 死亡率は北アフリカ,北アフリカ,北アフリカ栄養素 栄養素 栄養素 栄養素栄養失調症 栄養失調症について生理学 生理学とは人口の人口は,人口です.人口の特徴について人口のダイナミクス研究方法論 研究方法論農村人口 農村人口について社会経済的要因 社会経済的要因勉強 勉強 勉強 勉強 勉強スーダン スーダン スーダン生き残りについてです.ビタミンA - 投与方法と用量ビタミン ビタミン

さらに関連する動画

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

関連する概念動画

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...